COMMUNIQUÉS West-GlobeNewswire

Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
22/10/2026
Company leadership, leading cardiologists and trial investigators to discuss unmet patient needs, BACKBEAT and Virtue pivotal trials, and upcoming milestones; in person in New York City and via live webcast NEW HOPE, Pa [...]
NurExone Demonstrates Scalable Exosome Production, Supporting Its Modular Manufacturing Strategy and Commercial Growth
22/10/2026
Successful parallel production process maintains consistency while doubling exosome yield without increasing manufacturing time TORONTO and HAIFA, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: [...]
USA Peptides: Kylo Peptides Partners With Freedom Diagnostics for Independent Verification of Research Peptides
22/10/2026
Kylo Peptides Announces Partnership With Freedom Diagnostics Sheridan, Wyoming, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com/ ], a research peptide supplier for laboratory research, today [...]
Yaqrit announces Liver International publication of YAQ001 microbiome data in cirrhosis, supporting its development in serious liver and gut disorders
22/10/2026
YAQ001 associated with favorable shifts in gut microbial species and lower abundance of virulence and antibiotic resistance genes Trends toward improved markers of gut permeability and systemic inflammation Topline data [...]
SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
22/10/2026
Preliminary Unaudited Third Quarter Revenue Increased 256% Sequentially to Approximately $1.22 Million, Supported by Continued Arbli ™ Growth and the Commercial Launch of REZENOPY ™ Two FDA-Approved Commercial Products [...]
Candel Therapeutics Appoints Maria Ostrovsky as General Counsel
22/10/2026
Seasoned legal and compliance executive brings global product launch, strategic transaction and international operational experience as Candel prepares for its planned Biologics License Application (BLA) submission and [...]
Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
22/10/2026
Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the treatment of cardiac arrhythmia in Latvia First procedures successfully [...]
First Steps Developmental Services Opens Infant Assessment in Woburn
22/10/2026
The Every Milestone Project offers pre-diagnosis support for babies 2 to 12 months old, no referral required WOBURN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- First Steps Developmental Services has launched the Every [...]
4Tissue raises €7 million in Series A financing and appoints Stéphanie Dupont as CEO
22/10/2026
GHENT, Belgium, Oct. 22, 2026 (GLOBE NEWSWIRE) -- 4Tissue, a Belgian medtech company developing solutions for regenerative medicine, announces a €7 million Series A financing round and the appointment of Stéphanie [...]
SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases
22/10/2026
Intravenous SCY-247 was generally well tolerated in healthy participants, with no drug-related serious adverse events Once-daily intravenous doses of 50 mg or higher achieved exposures at or above the target identified [...]
Rectify to Present Translational Data Supporting RTY-406 as a Transformative Therapy for PSC and Other Hepatobiliary Diseases
22/10/2026
BOSTON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc ., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today [...]
Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026
22/10/2026
STOUGHTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood [...]
Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026
22/10/2026
WOBURN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will [...]
AskBio Announces 5 Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress
22/10/2026
Durham, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Five poster presentations will highlight exciting progress in AskBio’s adeno-associated virus (AAV) manufacturing technologies AskBio Inc. (AskBio), a gene therapy company [...]
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
22/10/2026
Positive IND-Enabling Proof-of-Concept Study Demonstrates Sustained Efficacy Without Observed Tolerance, Reduced Inflammation-Associated Swelling, and Favorable Tolerability MIAMI, Oct. 22, 2026 (GLOBE NEWSWIRE) -- MIRA [...]
Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
22/10/2026
PITTSBURGH, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its third quarter 2026 financial results on Monday, November 2, 2026, prior to the [...]
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
22/10/2026
Seven abstracts spanning CKD translational model studies and drug product characterization provide converging evidence supporting a multifactorial mechanism of action for rilparencel One clinical abstract presents a new [...]
Verrica Pharmaceuticals Announces Achievement of Milestones Unlocking Access to the Full $27.5 Million of Non-Dilutive Growth Capital Under Credit Facility
22/10/2026
– Company’s achievement of pre-defined revenue, growth and operational milestones increases facility commitment by $15.0 million – – Capital now available to support continued growth of the YCANTH® business and [...]
Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse
22/10/2026
In naturally aged mice treated from 80 weeks of age and followed until natural death, once-weekly PTC-2105 (25 mg/kg) significantly increased overall survival versus saline (log-rank p = 0.0142) “Speedy,” a PTC-2105- [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum